Decoding Myosin-3 mutational hotspots: Linking deleterious variants to Duchenne muscular dystrophy severity and psychiatric comorbidities

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One vol. 20, no. 7 (Jul 2025), p. e0328503
Autor principal: Hakami, Mohammed Ageeli
Otros Autores: Ahad Amer Alsaiari, Taj Mohammad, Shamsi, Anas
Publicado:
Public Library of Science
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3230449903
003 UK-CbPIL
022 |a 1932-6203 
024 7 |a 10.1371/journal.pone.0328503  |2 doi 
035 |a 3230449903 
045 2 |b d20250701  |b d20250731 
084 |a 174835  |2 nlm 
100 1 |a Hakami, Mohammed Ageeli 
245 1 |a Decoding Myosin-3 mutational hotspots: Linking deleterious variants to Duchenne muscular dystrophy severity and psychiatric comorbidities 
260 |b Public Library of Science  |c Jul 2025 
513 |a Journal Article 
520 3 |a Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder primarily caused by mutations in the dystrophin gene, leading to progressive muscle degeneration. While the loss of dystrophin is central to DMD pathogenesis, impaired muscle regeneration further exacerbates disease severity. As MYH3-encoding Myosin-3 is involved in muscle development and regeneration, we examined how it could be added to the list of possible contributors to DMD pathology. This study employed various computational tools such as PolyPhen-2, SIFT, and I-Mutant to analyze 486 MYH3 missense mutations and predict the structural and functional implications. We discovered 89 deleterious substitutions, of which 80 were pathogenic. Of these, 45 mutations were identified as likely to pathogenically alter Myosin-3 solubility, and 5 (G182A, R244C, R244H, H285Y, N483S) fell within evolutionarily conserved regions. The mutant G182A is of particular interest as it lies within the ATP-binding site, which may lead to an impairment of energy-dependent myosin activity. These mutations likely impair muscle regeneration, potentially intensifying the severity of dystrophy. Furthermore, we hypothesize that these functional deficiencies may not be limited to muscle pathogenesis and could be related to the development of neuropsychiatric comorbidities observed in DMD, although this remains to be experimentally confirmed. Our results emphasize the relevance of Myosin-3 in the pathogenesis of DMD and the importance of combined research on neuromuscular and psychiatric aspects to improve therapeutic approaches. 
653 |a Pathogenesis 
653 |a Muscles 
653 |a Decoding 
653 |a Myosin 
653 |a Mutation 
653 |a Muscular dystrophy 
653 |a Muscle contraction 
653 |a Regeneration 
653 |a Amino acids 
653 |a Pathology 
653 |a Degeneration 
653 |a Proteins 
653 |a Physicochemical properties 
653 |a Binding sites 
653 |a Mutation hot spots 
653 |a Dystrophy 
653 |a Mutants 
653 |a Missense mutation 
653 |a Dystrophin 
653 |a Solubility 
653 |a Structure-function relationships 
653 |a Comorbidity 
653 |a Software 
653 |a Duchenne's muscular dystrophy 
653 |a Social 
700 1 |a Ahad Amer Alsaiari 
700 1 |a Taj Mohammad 
700 1 |a Shamsi, Anas 
773 0 |t PLoS One  |g vol. 20, no. 7 (Jul 2025), p. e0328503 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3230449903/abstract/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3230449903/fulltext/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3230449903/fulltextPDF/embedded/75I98GEZK8WCJMPQ?source=fedsrch